Please login to the form below

Not currently logged in
Email:
Password:

Sosei appoints chief operating officer

Peter Bains also takes on the role of representative executive officer

Sosei Peter BainsTokyo, Japan-based Sosei has appointed Peter Bains as its chief operating officer and representative executive officer.

In this role, Bains will oversee all of the pharmaceutical firm's operational activities, reporting to Shinichi Tamura, Sosei's founder and group chairman.

Bains has nearly 30 years of experience in the pharmaceutical industry, bringing considerable strategic and operational leadership expertise to his new position.

He spent 23 years of his career at GlaxoSmithKline, first joining in 1996 as general manager of the former SmithKline Beecham before taking on a series of increasingly senior positions, including general manager of its operations in China, head of global marketing, and senior vice president of international commercial operations.

He has served as a non-executive director at Sosei since 2010, and has since worked at Syngene International, where he was chief executive and executive director, and Heptares Therapeutics, where he served as a director.

Bains said: “I am both personally honoured and also extremely excited at the prospect of taking up these new roles and I would like to thank Mr Tamura and the Sosei board for their trust and support.

“Sosei Group is now at a very dynamic point in its history as it seeks to expand its operational scope and scale, and I am looking forward to its rapid evolution into a truly global biopharmaceutical company.”

7th July 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics